Cambridge Investment Research Advisors, Inc. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$61,000
-43.5%
10,4310.0%0.00%
-100.0%
Q2 2021$108,00010,4310.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 999,275$37,403,00055.08%
New Leaf Venture Partners, L.L.C. 126,687$4,742,0002.31%
Cormorant Asset Management, LP 385,000$14,411,0002.22%
SECTORAL ASSET MANAGEMENT INC 529,920$19,835,0000.89%
PFM Health Sciences, LP 850,337$31,828,0000.74%
Partner Investment Management, L.P. 16,399$614,0000.25%
Tekla Capital Management LLC 137,766$5,157,0000.24%
Candriam S.C.A. 298,000$11,154,0000.23%
Eventide Asset Management 30,000$1,123,0000.12%
DRIEHAUS CAPITAL MANAGEMENT LLC 81,047$3,034,0000.12%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders